C00874-2023

SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)
Feb 2, 2023
2. SEC Identification Number
14812
3. BIR Tax Identification No.
000-110-888-000
4. Exact name of issuer as specified in its charter
CHEMICAL INDUSTRIES OF THE PHILIPPINES, INC.
5. Province, country or other jurisdiction of incorporation
METRO MANILA, PHILIPPINES
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
CHEMPHIL BUILDING, 851 A. ARNAIZ AVENUE MAKATI CITY Postal Code 1229
8. Issuer's telephone number, including area code
(02) 8687-8877
9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
COMMON STOCK P10 PAR VALUE 10,296,601
11. Indicate the item numbers reported herein
Item 9 - Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Chemical Industries of the Philippines, Inc.CIP

PSE Disclosure Form 4-3 - Amendments to Articles of Incorporation References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure

Amendment to Articles of Incorporation

Background/Description of the Disclosure

On 2 February 2023, at the Special Stockholders’ Meeting of Chemical Industries of the Philippines, Inc. (the “Corporation”), the Stockholders representing at least two-thirds of the outstanding capital stock of the Corporation, approved the amendment of the corporate name and principal office of the Corporation.

Date of Approval by
Board of Directors
Jan 25, 2023
Date of Approval by Stockholders Feb 2, 2023
Other Relevant Regulatory Agency, if applicable N/A
Date of Approval by Relevant Regulatory Agency, if applicable N/A
Date of Approval by Securities and Exchange Commission TBA
Date of Receipt of SEC approval TBA
Amendment(s)
Article No. From To
First That the name of said corporation shall be CHEMICAL INDUSTRIES OF THE PHILIPPINES, INC. That the name of said corporation shall be Uniholdings Inc.
Third That the principal office of the Corporation is established and located in Chemphil Building, 851 A. Arnaiz Avenue, Legaspi Village, Makati City. That the principal office of the Corporation is established and located in Elisco Road, Kalawaan, Pasig City
Rationale for the amendment(s)

First, changing its corporate name is in order to align with the proposed amendment of its business purpose to invest in and/or to engage in real-estate business.

Second, CIP deemed it best to transfer its principal place of business, in view of the sale of the land and building where the principal office of the Corporation is established. Changing its principal office to Pasig City will have the effect of making its branch office as its main principal place of business.

The timetable for the effectivity of the amendment(s)
Expected date of filing the amendments to the Articles of Incorporation with the SEC TBA
Expected date of SEC approval of the Amended Articles of Incorporation TBA
Effect(s) of the amendment(s) to the business, operations and/or capital structure of the Issuer, if any

The proposed corporate name is aligned with the proposed amendment of the Corporation's business purpose to invest in and/or to engage in real-estate business. With the proposed transfer of principal office in Pasig City, it is expected that the Corporation will prioritize its leasing activities, by investing in and/or to engaging in real-estate business thereat.

Other Relevant Information

Amending the previous disclosure to set forth the Stockholders' approval was secured today.

Filed on behalf by:
Name Nancy Ocampo-Omadto
Designation Compliance Officer